Tabex web site: https://www.tabex.net
Tabex 100 filmtabl x 1.5 mg Cytisine
Tabex.net addresses various clinical topics on Tabex (Cytisine): Pharmacodynamics of Cytisine, mechanism of action, toxicity, therapeutic range and clinical application as well as patient use details.
The broad clinical studies carried out, show that the therapy with the preparation Tabex results in giving up smoking in more than 57% of the patients.
In the human body, Cytisine plays the role of nicotine substitution substance, and reduces the period of interaction of the received nicotine with relevant nicotine receptors, i.e. the specific substance cytisine "substitutes" nicotine, acting on the same receptors, thus preventing the appearance of abstinence syndrome. This results in a gradual reduction and suspension of the psychic and physical dependency to nicotine in smokers.
Tabex is an original Bulgarian preparation of plant origin, intended for the treatment of tobacco smoking. The preparation is developed on the basis of the alkaloid Cytisine, contained in the plant Cytisus laborinum L. (Golden Rain acacia).
Cytisine possesses a structure and mechanism of action that are similar to those of nicotine, but it has much lower toxicity.
Tabex manifests one of the best results to date for the group of preparations, intended for tobacco smoking therapy.
Tabex is very well tolerated, and when applied in therapeutic doses, allows a gradual giving up of smoking without any side effects.
The total giving up of smoking should take place not later than the fifth day after the beginning of the therapy. Supplied in a package of 100 filmtablets of 1.5 mg Citysine
Tabex recommended therapeutic scheme
|Day of Treatment||Intake Intervals||Total Daily Tablets|
|Day 1 to 3||1 tablet every 2 hours||6 tablets daily|
|Day 4 to 12||1 tablet every 2.5 hours||5 tablets daily|
|Day 13 to 16||1 tablet every 3 hours||5 tablets daily|
|Day 17 to 20||1 tablet every 4 hours||3 tablets daily|
|Day 21 to 25||1 tablet every 6 hours||2 tablets daily|
|Click here for Important usage details|
Copyright © 2016-2017 BPG Ltd/Biogenic Stimulants, Inc. All rights reserved.